1. Australia
  2. All 3M Products
  3. Medical
  4. Skin Care
  5. No-Sting Barrier Films
  6. 3M™ Cavilon™ No Sting Barrier Film 1mL Wand 3343

3M™ Cavilon™ No Sting Barrier Film 1mL Wand 3343

  • 3M ID 70200770777

The intelligent choice to help prevent medical adhesive-related skin injury (MARSI) around infusion sites: CHG compatible³

Clinically proven, cost effective, long lasting protection from incontinence-associated dermatitis (IAD)¹'²

Will not clog or reduce absorbency of diapers or pads

View more details
Frequently viewed resources
PDF (1) Copy 26Safety Data Sheet (PDF)

Details

Highlights
  • The intelligent choice to help prevent medical adhesive-related skin injury (MARSI) around infusion sites: CHG compatible³
  • Clinically proven, cost effective, long lasting protection from incontinence-associated dermatitis (IAD)¹'²
  • Will not clog or reduce absorbency of diapers or pads
  • Protects intact or damaged skin
  • Sterile, non-cytotoxic³
  • Alcohol-free, sting-free
  • Hypoallergenic³
Take cover in proven protection. Cavilon No Sting Barrier Film is a unique terpolymer based, alcohol-free liquid barrier film that protects intact or damaged skin from bodily fluids, adhesive trauma, friction and incontinence. It is clinically proven, and trusted by clinicians to provide a high level of barrier protection of up to 72 hours from irritation due to incontinence.¹'² In fact, 3M has over 70 pieces of clinical evidence supporting the efficacy and cost-effectiveness of Cavilon No Sting Barrier Film in a wide range of clinical applications - substantially more evidence than any other moisture barrier or barrier film.³

Click here to learn more and to see what resources are available

It is designed to protect intact, damaged or 'at-risk' skin from urine, faeces, other body fluids, medical adhesive related skin injury (MARSI) and friction. It comes in a variety of easy to apply formats: 1ml foam applicator, 3ml foam applicator, 28ml pump spray and a stoma wipe. It lasts for up to 72 hours, and will not sting when applied to broken skin.

Suggested applications
  • Perineal skin protection from urine and faeces
  • Peri-stomal skin protection from adhesives, urine or faeces
  • Peri-wound protection from wound exudate
  • Peri-tube and device protection from drainage or bodily fluids
  • Skin protection from adhesives
  • Skin protection from friction
  • Management of skin during radiation therapy

Specifications

Boxes per Case

4.0

Brands

Cavilon™

Catalog Number

3343

Condition

I.V. Related, Wound Care, Dressing & Device Securement, Pressure Ulcer, Skin Care

Delivery System

Wand

Dressing and Device Securement Condition Type

Adhesive Trauma, Surgical Wound, Tube & Device Securement-Lightweight Tubes & Devices, Skin Injuries-Allergic & Irritant Contact Dermatitis, Skin Injuries-Maceration, Skin Injuries-Mechanical, Tube & Device Securement-Infusion & Monitoring

Hypoallergenic

Yes

IV Related Condition Type

CVC Dialysis, CVC PICC, Epidural Catheter, PIV, CVC Tunneled, Arterial Catheter, CVC Implanted Port, CVC Short-Term

Latex

No

Product Type

Barrier Film

Units per Case

100.0

Units per Pack

25

Volume (metric)

1 mL

Resources

1. Bliss DZ, Zehrer C, Savik K, Smith G, Hedblom E. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence. J WOCN 2007; 34(2):143-52.

2. Bale S, Tebble N, Jones VJ, Price PE. The benefits of introducing a new skin care protocol in patients cared for in nursing homes. (2004) J Tissue Viability 14(2): 44 – 50.

3. 3M Data on File.

4. Hart J. Assessment of the incontinence pad blocking potential of 3M™ Cavilon™ Durable Barrier Cream compared with Sudocrem™ and Zinc and Castor Oil. Nursing Scotland 2002, Issue: July/August.,1. Bliss DZ, Zehrer C, Savik K, Smith G, Hedblom E. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence. J WOCN 2007; 34(2):143-52.
2. Bale S, Tebble N, Jones VJ, Price PE. The benefits of introducing a new skin care protocol in patients cared for in nursing homes. (2004) J Tissue Viability 14(2): 44 – 50.
3. 3M data on file